161 related articles for article (PubMed ID: 36765039)
1. TRAF4-mediated ubiquitination-dependent activation of JNK/Bcl-xL drives radioresistance.
Dong X; Li X; Gan Y; Ding J; Wei B; Zhou L; Cui W; Li W
Cell Death Dis; 2023 Feb; 14(2):102. PubMed ID: 36765039
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance.
Li M; Gao F; Li X; Gan Y; Han S; Yu X; Liu H; Li W
Cell Death Dis; 2022 Dec; 13(12):1053. PubMed ID: 36535926
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitination of the DNA-damage checkpoint kinase CHK1 by TRAF4 is required for CHK1 activation.
Yu X; Li W; Liu H; Deng Q; Wang X; Hu H; Xu-Monette ZY; Xiong W; Lu Z; Young KH; Wang W; Li Y
J Hematol Oncol; 2020 May; 13(1):40. PubMed ID: 32357935
[TBL] [Abstract][Full Text] [Related]
4. TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis.
Singh R; Karri D; Shen H; Shao J; Dasgupta S; Huang S; Edwards DP; Ittmann MM; O'Malley BW; Yi P
J Clin Invest; 2018 Jul; 128(7):3129-3143. PubMed ID: 29715200
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells.
Yang J; Sun M; Zhang A; Lv C; De W; Wang Z
World J Surg Oncol; 2011 Oct; 9():117. PubMed ID: 21970601
[TBL] [Abstract][Full Text] [Related]
6. TRAF4 regulates ubiquitination-modulated survivin turnover and confers radioresistance.
Liao J; Qing X; Li X; Gan Y; Wang R; Han S; Li W; Song W
Int J Biol Sci; 2024; 20(1):182-199. PubMed ID: 38164179
[TBL] [Abstract][Full Text] [Related]
7. TRAF4 promotes lung cancer aggressiveness by modulating tumor microenvironment in normal fibroblasts.
Kim E; Kim W; Lee S; Chun J; Kang J; Park G; Han I; Yang HJ; Youn H; Youn B
Sci Rep; 2017 Aug; 7(1):8923. PubMed ID: 28827764
[TBL] [Abstract][Full Text] [Related]
8. The E3 ligase TRAF4 promotes IGF signaling by mediating atypical ubiquitination of IRS-1.
Yu W; Singh R; Wang Z; O'Malley BW; Yi P
J Biol Chem; 2021; 296():100739. PubMed ID: 33991522
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitination of tumor necrosis factor receptor-associated factor 4 (TRAF4) by Smad ubiquitination regulatory factor 1 (Smurf1) regulates motility of breast epithelial and cancer cells.
Wang X; Jin C; Tang Y; Tang LY; Zhang YE
J Biol Chem; 2013 Jul; 288(30):21784-92. PubMed ID: 23760265
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.
El Fajoui Z; Toscano F; Jacquemin G; Abello J; Scoazec JY; Micheau O; Saurin JC
Gastroenterology; 2011 Aug; 141(2):663-73. PubMed ID: 21683075
[TBL] [Abstract][Full Text] [Related]
11. A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation.
Jin HO; Seo SK; Woo SH; Lee HC; Kim ES; Yoo DH; Lee SJ; An S; Choe TB; Kim JI; Hong SI; Rhee CH; Park IC
Lung Cancer; 2008 Sep; 61(3):317-27. PubMed ID: 18281123
[TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptor 2 stabilizes Bcl-xL and regulates EGFR-targeted therapy response in colorectal cancer.
Li W; Ma Y; He L; Li H; Chu Y; Jiang Z; Zhao X; Nie Y; Wang X; Wang H
Cancer Lett; 2021 Oct; 517():14-23. PubMed ID: 34098062
[TBL] [Abstract][Full Text] [Related]
13. TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis.
Zhang L; Zhou F; García de Vinuesa A; de Kruijf EM; Mesker WE; Hui L; Drabsch Y; Li Y; Bauer A; Rousseau A; Sheppard KA; Mickanin C; Kuppen PJ; Lu CX; Ten Dijke P
Mol Cell; 2013 Sep; 51(5):559-72. PubMed ID: 23973329
[TBL] [Abstract][Full Text] [Related]
14. TRAF4 Promotes the Proliferation of Glioblastoma by Stabilizing SETDB1 to Activate the AKT Pathway.
Gu H; Zhu S; Peng C; Wei Z; Shen Y; Yuan C; Yang H; Cui H; Yang L
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077559
[TBL] [Abstract][Full Text] [Related]
15. TRAF4-Mediated LAMTOR1 Ubiquitination Promotes mTORC1 Activation and Inhibits the Inflammation-Induced Colorectal Cancer Progression.
Zhao L; Gao N; Peng X; Chen L; Meng T; Jiang C; Jin J; Zhang J; Duan Q; Tian H; Weng L; Wang X; Tan X; Li Y; Qin H; Yuan J; Ge X; Deng L; Wang P
Adv Sci (Weinh); 2024 Mar; 11(12):e2301164. PubMed ID: 38229144
[TBL] [Abstract][Full Text] [Related]
16. TRAF4 positively regulates the osteogenic differentiation of mesenchymal stem cells by acting as an E3 ubiquitin ligase to degrade Smurf2.
Li J; Wang P; Xie Z; Wang S; Cen S; Li M; Liu W; Tang S; Ye G; Zheng G; Su H; Ma M; Wu X; Wu Y; Shen H
Cell Death Differ; 2019 Dec; 26(12):2652-2666. PubMed ID: 31076633
[TBL] [Abstract][Full Text] [Related]
17. Bcl-xL blocks activation of related adhesion focal tyrosine kinase/proline-rich tyrosine kinase 2 and stress-activated protein kinase/c-Jun N-terminal protein kinase in the cellular response to methylmethane sulfonate.
Pandey P; Avraham S; Place A; Kumar V; Majumder PK; Cheng K; Nakazawa A; Saxena S; Kharbanda S
J Biol Chem; 1999 Mar; 274(13):8618-23. PubMed ID: 10085098
[TBL] [Abstract][Full Text] [Related]
18. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
[TBL] [Abstract][Full Text] [Related]
19. Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation.
Ni F; Yan CY; Zhou S; Hui PY; Du YH; Zheng L; Yu J; Hu XJ; Zhang ZG
Cancer Chemother Pharmacol; 2018 Oct; 82(4):593-605. PubMed ID: 30032449
[TBL] [Abstract][Full Text] [Related]
20. miR-29s function as tumor suppressors in gliomas by targeting TRAF4 and predict patient prognosis.
Shi C; Rao C; Sun C; Yu L; Zhou X; Hua D; Wang R; Luo W; Jiang Z; Zhou J; Wang Q; Yu S
Cell Death Dis; 2018 Oct; 9(11):1078. PubMed ID: 30348972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
